Doug Parker, American Airlines' long-serving CEO, will retire in March of next year, the carrier confirmed Tuesday.

GlaxoSmithKline and its U.S. partner, Vir Biotechnology, said Tuesday that their COVID antibody is effective against all mutations of the new Omicron variant.

Tesla shares are set to snap a four-day losing streak after Elon Musk says Congress should not approve the Biden infrastructure bill that includes EV subsidies.

Intel plans to list Mobileye, the self-driving car division is purchased in 2017, sometime next year in a deal that could value the group at around $50 billion.

James 'Rev Shark" Deporre says investors shouldn't ignore the latest variant.

Stocks futures extend gains as Omicron risks fade, Glaxo and Vir Bio say COVID therapy effective against variant; Intel plans potential $50 billion Mobileye IPO; Samsung merges phone and electronics division in major restructuring and Elon Musk says Biden's EV incentives shouldn't pass congress.

But some chip names still have relatively low valuations.

Jim Cramer says investors should ignore pre-market jitters and focus on the three things the market really cares about.